INHIBITION OF ANGIOTENSIN-I RESPONSE BY CILAZAPRIL AND ITS TIME COURSE IN NORMAL VOLUNTEERS

被引：26

作者：

WELLSTEIN, A

ESSIG, J

BELZ, GG

机构：

[1] INST KARDIOVASK THERAPIE,WIESBADEN,FED REP GER

[2] UNIV GIESSEN KLINIKUM,ZENTRUM PHARMAKOL,D-6300 GIESSEN,FED REP GER

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 06期

关键词：

D O I：

10.1038/clpt.1987.89

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：639 / 644

页数：6

共 13 条

[1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].

ARUNLAKSHANA, O ;

SCHILD, HO .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58

[2]

BELZ GG, 1986, MED KLIN, V81, P524

[3] HEMODYNAMIC-RESPONSES TO ANGIOTENSIN-I IN NORMAL VOLUNTEERS AND THE ANTAGONISM BY THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL [J].

BELZ, GG ;

ESSIG, J ;

WELLSTEIN, A .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (02) :219-224

[4]

BENET LZ, 1985, PHARMACOL BASIS THER, P1663

[5] EFFECTS OF SINGLE DOSES OF THE CONVERTING-ENZYME-INHIBITOR CILAZAPRIL IN NORMAL VOLUNTEERS [J].

DAMORE, TF ;

BUSSIEN, JP ;

NUSSBERGER, J ;

WAEBER, B ;

TURINI, GA ;

BRUNNER, HR ;

KLER, L ;

FRANCIS, RJ .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (01) :26-31

[6]

FERGUSON RK, 1977, LANCET, V1, P775

[7] ENALAPRIL - A REVIEW OF HUMAN PHARMACOLOGY [J].

GOMEZ, HJ ;

CIRILLO, VJ ;

IRVIN, JD .

DRUGS, 1985, 30 :13-24

[8] THE DESIGN OF A NEW GROUP OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].

HASSALL, CH ;

KROHN, A ;

MOODY, CJ ;

THOMAS, WA .

FEBS LETTERS, 1982, 147 (02) :175-179

[9] CLINICAL PHARMACOKINETICS OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - A REVIEW [J].

KUBO, SH ;

CODY, RJ .

CLINICAL PHARMACOKINETICS, 1985, 10 (05) :377-391

[10] BIOLOGICAL PROPERTIES OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL [J].

NATOFF, IL ;

NIXON, JS ;

FRANCIS, RJ ;

KLEVANS, LR ;

BREWSTER, M ;

BUDD, J ;

PATEL, AT ;

WENGER, J ;

WORTH, E .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (03) :569-580

← 1 2 →